Medical innovation

Even bones grow in the Kepler University laboratory

The development can reduce complication rates in the treatment of bone defects.

(Bild: stock.adobe.com/contrastwerkstatt)

How can complication rates be reduced and the number of stays in surgery be cut, which in turn reduces the burden on the healthcare system? Researchers at the Institute for Chemistry of Polymers at Kepler University in Linz are also looking into this question. They have developed biomaterials that are used to produce synthetic bones.

"The materials are made from natural substances, such as those found in human bone. They can be specifically adapted to the defect and for each patient using 3D printing and do not remain in the body, but are broken down over time," explained Eleni Priglinger from the Johannes Kepler University's Med Campus at the presentation of the State Prize for Innovation for the "synthetic bones" from Linz.

Ian Teasdale and Eleni Priglinger (right) with the State Prize for Innovation 2024, which they received for the production of synthetic bones.

(Bild: Wenzel Markus)

"We take amino acids and chemically modify them in the lab to make them as easy to work with as plastic," added Ian Teasdale from the Institute for Chemistry of Polymers, which is housed in the TNF Tower on the JKU campus.

Ian Teasdale (left), Stephan Haudum from the Institute of Polymer Chemistry and Eleni Priglinger and Laura Müller (right) from the Med Campus conducted research.

(Bild: zVg)

Here on the seventh floor, everything revolves around research in the field of polymer chemistry - and the development of synthetic bones. After intensive research work, it has been possible to produce biodegradable materials that can be used to treat bone defects.

"During development, we were specifically inspired by nature," reveals Teasdale. Priglinger is certain: "It will change patients' lives." Lower complication rates and fewer visits to the operating theater should reduce the burden on patients and the healthcare system.